Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Contemp Clin Trials. 2020 Jan 7;89:105934. doi: 10.1016/j.cct.2020.105934

Table 1.

Inclusion and exclusion criteria

Inclusion criteria
Men and women 50–85 years old
Ability to walk for six minutes
Diabetic group: Diagnosis and treatment for T2DM with non-insulin oral or injectable agents or diet
Control group: Fasting plasma glucose <126 mg/dL and HbA1c <6.5%
Exclusion criteria
Insulin use
Insulin allergy
Type 1 Diabetes Mellitus
History of severe hypoglycemia
Dementia
MMSE scores ≤20
Liver failure or transplant
Renal failure or transplant
Serious systemic disease that would interfere with conduction of the trial
Acute medical condition that required hospitalization or surgery within the past 6 months (e.g., malignancies, myocardial infarction, stroke)

Abbreviations: T2DM: Type 2 Diabetes Mellitus; HbA1c: Hemoglobin-A1c; MMSE Mini Mental State Examination